Cargando…
AMG 900, a potent inhibitor of aurora kinases causes pharmacodynamic changes in p-Histone H3 immunoreactivity in human tumor xenografts and proliferating mouse tissues
BACKGROUND: The Aurora family of serine-threonine kinases are essential regulators of cell division in mammalian cells. Aurora-A and –B expression and kinase activity is elevated in a variety of human cancers and is associated with high proliferation rates and poor prognosis. AMG 900 is a highly pot...
Autores principales: | Juan, Gloria, Bush, Tammy L, Ma, Connie, Manoukian, Raffi, Chung, Grace, Hawkins, Jennifer M, Zoog, Stephen, Kendall, Richard, Radinsky, Robert, Loberg, Robert, Friberg, Greg, Payton, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221688/ https://www.ncbi.nlm.nih.gov/pubmed/25367255 http://dx.doi.org/10.1186/s12967-014-0307-x |
Ejemplares similares
-
An Aurora kinase inhibitor, AMG900, inhibits glioblastoma cell proliferation by disrupting mitotic progression
por: Ryu, Jaewook, et al.
Publicado: (2018) -
Combining the pan-aurora kinase inhibitor AMG 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancer
por: Paller, Channing J, et al.
Publicado: (2014) -
Pharmacokinetic-Pharmacodynamic Relationship of Erenumab (AMG 334) and Capsaicin-Induced Dermal Blood Flow in Healthy and Migraine Subjects
por: Vu, Thuy, et al.
Publicado: (2017) -
Safety, pharmacokinetics and pharmacodynamics of AMG 811, an anti-interferon-γ monoclonal antibody, in SLE subjects without or with lupus nephritis
por: Boedigheimer, Michael J, et al.
Publicado: (2017) -
A first-in-human study of AMG 208, an oral MET inhibitor, in adult patients with advanced solid tumors
por: Hong, David S., et al.
Publicado: (2015)